Bülent Özbay

Bülent Özbay

Auto-generated profile, based on publicly available information

Bülent Özbay

Department of Pulmonary Medicine, Faculty of Medicine Muğla Sıtkı Kocman University Muğla Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2025 in Clinical Cardiology
Verified
Journal Article
Open access
YÖYasin Özen
Yasin Özen
MOMustafa Bilal Ozbay
Mustafa Bilal Ozbay
Zahin ShahriarZahin Shahriar
Zahin Shahriar
HTHüseyin TEZCAN
Hüseyin TEZCAN
ATAbdullah Tuncez
Abdullah Tuncez
BÖBülent Özbay
Bülent Özbay
Background: Naples Prognostic Score (NPS), a composite index incorporating inflammatory and nutritional markers, has emerged as a potential prognostic tool in various cardiovascular conditions; however, no meta‐analysis has yet pooled the available evidence to comprehensively assess its prognostic utility. Objectives: To evaluate the association of NPS with clinical outcomes, including all‐cause mortality, in‐hospital mortality, no‐reflow (NR) phenomenon, and left ventricular ejection fraction (LVEF), in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). Methods: MEDLINE, Cochrane, and EMBASE databases were searched for studies comparing high and low NPS groups in ACS patients undergoing PCI. Random‐effects models were used to pool risk ratios (RR) for binary outcomes and mean differences (MD) for continuous outcomes. Heterogeneity was assessed with I² statistics. Statistical analyses were performed using Review Manager 5.4, and R, version 4.2.2. Results: We included seven studies comprising 13 268 patients, with 5628 (42.4%) patients in the low NPS group. Low NPS was significantly associated with decreased all‐cause mortality (RR: 0.42; 95% CI: 0.32–0.55; I² = 48%) and decreased incidence of NR (RR: 0.60; 95% CI: 0.40–0.88; I² = 83%). Patients with low NPS also had higher LVEF (MD: −2.69%; 95% CI: −3.41 to −1.97; I² = 99%). No significant difference was observed in in‐hospital mortality (RR: 0.54; 95% CI: 0.28–1.05; I² = 94%). Conclusion: In ACS patients undergoing PCI, elevated NPS was associated with worse clinical outcomes. These findings support the use of NPS as a practical, biomarker‐based tool for risk stratification in this population.

9 October 2026 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
MOMustafa Bilal Ozbay
Mustafa Bilal Ozbay
YÖYasin Özen
Yasin Özen
BÖBülent Özbay
Bülent Özbay
Click on the article title to read more.